Related references
Note: Only part of the references are listed.Oleogels Based on Palmitic Acid and Safflower Oil: Novel Formulations for Ocular Drug Delivery of Voriconazole
Biswaranjan Mohanty et al.
EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY (2020)
Nutritional Aspects in Inflammatory Bowel Diseases
Paola Balestrieri et al.
NUTRIENTS (2020)
Leucine-rich alpha-2 glycoprotein 1, high mobility group box 1, matrix metalloproteinase 3 and annexin A1 as biomarkers of ulcerative colitis endoscopic and histological activity
Panagiotis Kourkoulis et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2020)
MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice
Yuhua Tian et al.
GASTROENTEROLOGY (2019)
Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients
Sung Chul Park et al.
CELLS (2019)
Role of the oil on glyceryl monostearate based oleogels
Ana Caroline Ferro et al.
FOOD RESEARCH INTERNATIONAL (2019)
Isolation, Formulation, and Efficacy Enhancement of Morin Emulsified Carriers Against Lung Toxicity in Rats
Alaadin E. El-Haddad et al.
AAPS PHARMSCITECH (2018)
Roflumilast, type 4 phosphodiesterase inhibitor, attenuates inflammation in rats with ulcerative colitis via down-regulation of iNOS and elevation of cAMP
Nahla E. El-Ashmawy et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Self-Assembling Raloxifene Loaded Mixed Micelles: Formulation Optimization, In Vitro Cytotoxicity and In Vivo Pharmacokinetics
Radhika Kanade et al.
AAPS PHARMSCITECH (2018)
Immunological pathogenesis of inflammatory bowel disease
Seung Hoon Lee et al.
INTESTINAL RESEARCH (2018)
Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis
Shinichiro Shinzaki et al.
JOURNAL OF CROHNS & COLITIS (2017)
CD14 Plays a Protective Role in Experimental Inflammatory Bowel Disease by Enhancing Intestinal Barrier Function
Stephanie Buchheister et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Edible oleogels for the oral delivery of lipid soluble molecules: Composition and structural design considerations
Chloe M. O'Sullivan et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2016)
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review
Ayokunle T. Abegunde et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Role of HMGB1 as a Suitable Biomarker of Subclinical Intestinal Inflammation and Mucosal Healing in Patients with Inflammatory Bowel Disease
Francesca Palone et al.
INFLAMMATORY BOWEL DISEASES (2014)
Preparation of sildenafil citrate microcapsules and in vitro/in vivo evaluation of taste masking efficiency
Eun-Jin Yi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Ulcerative Colitis: Epidemiology, Diagnosis, and Management
Joseph D. Feuerstein et al.
MAYO CLINIC PROCEEDINGS (2014)
Solubility and Permeability Studies of Aceclofenac in Different Oils
Muhammad Zubair Malik et al.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH (2014)
Inflammatory bowel disease: clinical aspects and treatments
Marc Fakhoury et al.
JOURNAL OF INFLAMMATION RESEARCH (2014)
Organogels, hydrogels and bigels as transdermal delivery systems for diltiazem hydrochloride
Mahmoud Mokhtar Ibrahim et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Formulation and In vitro Evaluation of Fluconazole Topical Gels
Aml Mekkawy et al.
BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH (2013)
Effect of Composition on the Properties of Tween-80-Span-80-Based Organogels
Sai Sateesh Sagiri et al.
DESIGNED MONOMERS AND POLYMERS (2012)
Development of span 80-tween 80 based fluid-filled organogels as a matrix for drug delivery
Charulata Bhattacharya et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2012)
Oleogel: A promising base for transdermal formulations
Rajkapoor Balasubramanian et al.
ASIAN JOURNAL OF PHARMACEUTICS (2012)
Colon-targeted celecoxib-loaded Eudragit® S100-coated poly-ε-caprolactone microparticles: Preparation, characterization and in vivo evaluation in rats
Dalia M. Ghorab et al.
DRUG DELIVERY (2011)
Rheology of oleogels based on sorbitan and glyceryl monostearates and vegetable oils for lubricating applications
R. Sanchez et al.
GRASAS Y ACEITES (2011)
iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases
Satoshi Serada et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Inflammatory Bowel Disease
Arthur Kaser et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Surfactant effects on the physical characteristics of Amphotericin B-containing nanostructured lipid carriers
S. W. Tan et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2010)
Mechanism of Dissolution Enhancement and Bioavailability of Poorly Water Soluble Celecoxib by Preparing Stable Amorphous Nanoparticles
Yinghui Liu et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2010)
Design and optimization of a new self-nanoemulsifying drug delivery system
Lijuan Wang et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2009)
Viability and permeability across Caco-2 cells of CBZ solubilized in fully dilutable microemulsions
Anna Kogan et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2008)
Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process
Min-Soo Kim et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Organogels and their use in drug delivery - A review
Anda Vintiloiu et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis
M. A. Alvarez-Soria et al.
OSTEOARTHRITIS AND CARTILAGE (2008)
In Situ-forming oleogel implant for rivastigmine delivery
Anda Vintiloiu et al.
PHARMACEUTICAL RESEARCH (2008)
Celecoxib inhibits production of MMP and NO via down-regulation of NF-kappa B and JNK in a PGE2 independent manner in human articular chondrocytes
R. Tsutsumi et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial
Francis Ka Leung Chan et al.
LANCET (2007)
Evaluation of the physical stability of two oleogels
Isabel F. Almeida et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques
Sajeev Chandran et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2006)
Serum trefoil factors in patients with inflammatory bowel disease
Henning Gronbaek et al.
DIGESTION (2006)
Improved in vitro permeation of nabumetone across rat skin from 1-O-alkylglycerol/lecithin stabilized o/w nanoemulsions
B. Madhusudhan et al.
JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY (2006)
N-Acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure
RA Pinho et al.
ENVIRONMENTAL RESEARCH (2005)
Topical absorption of piroxicam from organogels -: in vitro and in vivo correlations
T Pénzes et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
New insights into COX-2 biology and inhibition
P Patrignani et al.
BRAIN RESEARCH REVIEWS (2005)
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study
DJ Graham et al.
LANCET (2005)
Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: Elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis
C Schmidt et al.
INFLAMMATORY BOWEL DISEASES (2005)
Real-time quantification of microRNAs by stem-loop RT-PCR
CF Chen et al.
NUCLEIC ACIDS RESEARCH (2005)
Amphiphilogels for drug delivery: Formulation and characterization
N Jibry et al.
PHARMACEUTICAL RESEARCH (2004)
Solid lipid nanoparticles as carrier for sunscreens:: in vitro release and in vivo skin penetration
SA Wissing et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat
S Cuzzocrea et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats
S Cuzzocrea et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Share Paper
